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Background:  The NHQR tracks changes in measures of the quality of US health care provided for AMI and other conditions.
Methods:  This sequential cross-sectional analysis included process measure data from Medicare’s Quality Improvement Organization (QIO) 
Program. For sample all-payer discharges with specific diagnoses, QIO data include receipt of recommended care components not contraindicated 
in individual patients (pts). For AMI pts meeting certain criteria, these components include giving aspirin within 24 hrs of arrival, giving beta-blockers 
within 24 hrs of arrival, prescribing angiotensin-II converting enzyme inhibitors (ACEis) or angiotensin receptor blockers (ARBs) at discharge in pts 
with left ventricular systolic dysfunction, and starting fibrinolysis within 30 mins of arrival or percutaneous coronary intervention (PCI) within 90 mins 
of arrival. Composite scores measure the proportions of instances when pts receive individual care components for which they are eligible. AHRQ’s 
Nationwide Inpatient Sample (NIS) captures all discharges from a stratified random sample of ~20% of non-federal US acute care hospitals. For 
AMI pts meeting certain criteria, the NIS estimated nationwide inpatient mortality as adjusted for age, gender and mortality risk based on All Patient 
Refined Diagnostic Related Groups.
Results:  Nationwide, aspirin use within 24 hrs of admission rose from 95.2% in 2005 to 97.2% in 2007; beta-blocker use rose from 91.6% to 
94.4%. ACEi/ARB prescription rose from 83.4% to 91.3%. Timely fibrinolysis rose from 37.9% to 50.0%; for PCI it rose from 42.1% to 71.8%. National 
composite scores rose from 83.2% in 2005 to 90.3% in 2007. Scores for specific measures varied across states, as did composite scores (range = 
78.3% - 94.8% in 2007 alone). For 2005-07, NIS-estimated adjusted mortality fell from 77.5 to 67.3/1,000 AMI discharges.
Conclusions:  For 2005-07, process measure performance improved, especially for timely PCI. Variation across states and across measures 
identifies some successes as well as possible opportunities for improvement. Concurrent decreases in inpatient AMI mortality seen in a larger 
dataset may have multiple causes but are still encouraging.
